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Edited by Robert BaroukiAbstract An imprinted gene, paternally expressed gene (peg)
10, was isolated as one of the genes expressed early in adipogen-
esis. The expression of peg10 was elevated after the addition of
inducers, and was detected in adipocyte diﬀerentiable 3T3-L1
cells, but not observed in the non-adipogenic cell line NIH-
3T3. Moreover, the knockdown of peg10 by RNA interference
(RNAi) inhibited the diﬀerentiation of 3T3-L1 cells into lipid-la-
den adipocytes. Interestingly, peg10 RNAi-treatment reduced
the expressions of C/EBPb and C/EBPd, and inhibited mitotic
clonal expansion. These ﬁndings strongly indicate that peg10
plays a crucial role at the immediate early stage of adipocyte dif-
ferentiation.
 2007 Federation of European Biochemical Societies. Pub-
lished by Elsevier B.V. All rights reserved.
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Obesity is related to many diseases, such as hypertension,
heart disease, and diabetes. Obesity results from an imbalance
between energy intake and energy expenditure, which leads to
a pathological accumulation of adipose tissue [1]. This devel-
opment of adipose tissue is caused by hypertrophy and hyper-
plasia of adipocytes. Therefore, an understanding of the
molecular basis of hyperplasia as well as hypertrophy would
contribute to the establishment of medical treatments to pre-
vent health risks that can cause serious illness and death.
One explanation for the increase in the number of adipocytes
is that preadipocytes diﬀerentiate into lipid-laden adipocytes,
and newly generated cells function as mature adipocytes. Re-
cent studies have revealed that several genes, such as those
for peroxisome proliferator-activated receptor c (PPARc)
and CCAAT/enhancer-binding protein a (C/EBPa), play
important roles in the mid and late stages of adipocyte diﬀer-
entiation [2–4]. The events occurring during the mid- to late-Abbreviations: C/EBP, CCAAT/enhancer-binding protein; DMEM,
Dulbecco’s modiﬁed Eagle’s medium; fad, factor for adipocyte
diﬀerentiation; FBS, fetal bovine serum; ORF, open reading frame;
PBS, phosphate-buﬀered saline; PCR, polymerase chain reaction;
PPARc, peroxisome proliferator-activated receptor c; RNAi, RNA
interference; RT-PCR, reverse transcriptase coupled polymerase chain
reaction; shRNA, short hairpin RNA; UTR, untranslated region
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doi:10.1016/j.febslet.2007.07.074phase of diﬀerentiation are relatively well characterized, but
the molecular mechanisms underlying the early stages of adi-
pogenesis remain unknown.
To elucidate the initial step of adipocyte diﬀerentiation, we
have previously isolated genes whose expression is induced in
the early stages of the diﬀerentiation process, using mouse
3T3-L1 ﬁbroblastic cells. Using the PCR-subtraction system,
we isolated 102 genes, including genes for transcription factors
and signaling proteins [5–7]. Of these genes, 46 seem to be un-
known genes, whose functions remain unclear. We previously
isolated some full-length cDNAsofunknowngenes and revealed
that several of them are novel genes, such as fad24, fad104 and
fad158, which positively regulate adipogenesis [8–10].
Here, we report the identiﬁcation of one of the unknown
genes as paternally expressed gene peg10 and the involvement
of peg10 in adipocyte diﬀerentiation. Its expression was elevated
during the diﬀerentiation of 3T3-L1 cells. Up-regulation of
peg10 expression was detected in adipocyte diﬀerentiable 3T3-
L1, but not in the non-adipogenic cell line NIH-3T3. RNA
interference (RNAi)-mediated knockdown of peg10 inhibited
the diﬀerentiation of 3T3-L1 cells. Moreover, peg10 RNAi-
treatment impaired mitotic clonal expansion (MCE), which is
necessary for adipocyte diﬀerentiation. Interestingly, the
expression of C/EBPb and C/EBPd at the immediate early stage
of the diﬀerentiation process was inhibited by the knockdown of
peg10. Taken together, these results indicate that peg10 plays
important roles in the early stages of adipocyte diﬀerentiation.2. Materials and methods
2.1. RNA isolation and real-time quantitative RT-PCR (Q-PCR)
Total RNA was extracted with TRIzol (Invitrogen, Carlsbad, CA,
USA) according to the manufacturer’s instructions. The total RNA
was converted to the single cDNA using a random primer and Rever-
Tra Ace (Toyobo, Osaka, Japan). The cDNA was used as template for
Q-PCR. An ABI PRISM 7000 sequence detection system (Applied
Biosystems, Foster City, CA, USA) was used to perform the Q-
PCR. The pre-designed primers and probe sets for peg10, PPARc,
C/EBPa, C/EBPb, C/EBPd, aP2, and 18S rRNA were obtained from
Applied Biosystems. The reaction mixture was prepared using a Taq-
Man Universal PCR Master Mix (Applied Biosystems) according to
the manufacturer’s instructions. The mixture was incubated at 50 C
for 2 min and at 95 C for 10 min, and then the PCR was performed
at 95 C for 15 s and at 60 C for 1 min for 40 cycles. Relative standard
curves were generated in each experiment to calculate the input
amounts of the unknown samples.
2.2. Cell culture and diﬀerentiation
Mouse 3T3-L1 (ATCC CL173) preadipocyte cells were maintained
in Dulbecco’s modiﬁed Eagle’s medium (DMEM) containing 10% calf
serum. For the diﬀerentiation experiment, the medium was replaced
with DMEM containing 10% fetal bovine serum (FBS), 10 lg/mlblished by Elsevier B.V. All rights reserved.
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at 2 days post-conﬂuence. After 2 days, the medium was changed
to DMEM containing 5 lg/ml insulin and 10% FBS, then the cells
were refed every 2 days. Mouse NIH-3T3 (clone 5611, JCRB 0615)
ﬁbroblastic cells were maintained in DMEM containing 10% calf
serum.
2.3. RNAi experiment
The three target regions in the open reading frame (ORF) of mouse
peg10 (GenBanke Accession No. NM_130877); region 1 at 481–
501 bp (nucleotide A in the translation initiation codon is the ﬁrst
nucleotide), region 2 at 659–679 bp, and region 3 at 1201–1221 bp,
were selected according to the Qiagen siRNA online design tool
(http://sirna.qiagen.com/) for the RNAi of peg10. A 19-nucleotide
short-hairpin RNA (shRNA)–coding fragment with a 5 0-TTCAAGA-
GA-3 loop was subcloned into the ApaI/EcoRI site of pSilencer 1.0-U6
(Ambion, Inc. Austin, TX, USA). As a negative control, the scrambled
fragment 5 0-GTAAGATGAGGCAATGGAG-3 0 which does not have
similarity with any mRNA listed in GenBank was generated. The
transfection of shRNA expression vectors into 3T3-L1 cells was per-
formed with Nucleofector (Amaxa, Cologne, Germany) using Cell
Line Nucleofector Kit V (Amaxa). 3T3-L1 cells were harvested and
resuspended in Nucleofector solution at 2.0 · 106 cells/100 ll. After
the addition of shRNA expression vectors (9 lg), the cells were trans-
fected using program ‘T-20’ of Nucleofector. Then, they were plated
on 12- or 24-well plates. The 3T3-L1 cells were subjected to diﬀerenti-
ation experiments 3 days after the transfection. Diﬀerentiation experi-
ments were carried out using the same medium as described above. The
cell counts were performed with 24-well plates.
2.4. Cell counts
Cells were gently rinsed with PBS (phosphate-buﬀered saline) with-
out Ca2+ and Mg2+ (PBS-), and trypsinized with the use of trypsin
(0.25%)-EDTA (0.1%) solution in PBS- for 5 min at 37 C, 5% CO2.
The trypsinized cells were subjected to cell counts using a hemocytom-
eter.3. Results and discussion
3.1. Expression of peg10 during the early stage of adipocyte
diﬀerentiation
With the PCR-subtraction method, we isolated 46 unknown
genes, the expression of each of which was up-regulated 3 h
after the diﬀerentiation was induced. Since the fragments ob-
tained with this protocol were only 300–500 bp long, it was
necessary to isolate the full-length cDNAs and identify the
ORF of unknown genes. One of these unknown genes was
identiﬁed as peg10, because the subtracted fragment showed
identity to the 3 0-UTR of mouse peg10, which was later listed
in updated databases. Mouse peg10 is a single-copy gene lo-
cated on proximal chromosome 6. peg10 is a retrotranspo-
son-derived gene, which encodes pol-gag like peptides [11,12].
peg10 has two overlapping ORFs (RF1 and RF2), which re-
sults in two proteins being generated from a single mRNA:
PEG10-RF1, which is a non-shifting product, and PEG10-
RF1/2, which is generated as a RF1-RF2 fusion protein by
1 ribosomal frameshifting [12,13]. Recently, it was reported
that the knockout of peg10 in mice resulted in early embryonic
death owing to defects in the placenta [14]. Moreover, studies
showed that human peg10 was also involved in human hepato-
cellular carcinogenesis [15,16]. However, it is unclear whether
peg10 is related to adipocyte diﬀerentiation or not.
To investigate the role of peg10 in adipocyte diﬀerentiation,
we ﬁrst determined the peg10 expression proﬁle during the dif-
ferentiation process by Q-PCR (Fig. 1). The level of peg10
mRNA was immediately increased, reaching a peak at 3 h,
after the diﬀerentiation was induced, and returned to basal lev-els by 12 h. From 1 day after the induction, the peg10 mRNA
expression was re-induced and continued to increase until day
8. It seems that there was an another peak at day 3. Similar
expression proﬁles were obtained from three independent
Northern blot analyses (data not shown). We also determined
the gene expression of early and late markers of adipocyte dif-
ferentiation during the diﬀerentiation process. The increases in
the expression of late markers, such as aP2, PPARc, and C/
EBPa, were initially observed from 2 to 3 days after the induc-
tion and continued as the diﬀerentiation progressed.
The expression of C/EBPb and C/EBPd, which are early
markers and play early catalytic roles in the diﬀerentiation
pathway, was immediately elevated, reached a peak at 1–3 h
post-induction, and declined gradually at the later stages. In
summary, peg10 mRNA expression was transiently induced
at the early stages of adipocyte diﬀerentiation, having the same
timing as the immediate early expression of C/EBPb and C/
EBPd. In the late stages of the diﬀerentiation process, the
expression of peg10 mRNA was re-induced, ahead of the in-
creases in the expression of aP2, PPARc, and C/EBPa, and
continued to increase as the diﬀerentiation progressed. These
results suggest that peg10 may have several diﬀerent functions
during adipocyte diﬀerentiation.3.2. Expression proﬁles of peg10 in diﬀerentiating and non-
diﬀerentiating cells
We next determined whether peg10 expression was restricted
to cells in a state of diﬀerentiation or not. 3T3-L1 cells give rise
to adipocytes when exposed to inducers 2 days after reaching a
state of conﬂuence, whereas proliferating 3T3-L1 cells do not
diﬀerentiate even in the presence of inducers. Another mouse
ﬁbroblastic cell line, NIH-3T3, does not diﬀerentiate into adi-
pocytes in either a postconﬂuent or proliferating state. These
two cell lines were treated with inducers for 3 h while in a post-
conﬂuent (growth-arrested) or proliferating state. Q-PCR
showed that remarkable induction only occurred in the
growth-arrested 3T3-L1 cells, and that peg10 mRNA was
not detected in either proliferating or growth-arrested NIH-
3T3 cells, suggesting that the elevation of peg10 expression
was restricted to the adipocyte diﬀerentiable state (Fig. 2).
The same results were obtained by Northern blot analyses
(data not shown). This result implies that peg10 plays some
functional role in adipocyte diﬀerentiation.3.3. Eﬀect of the knockdown of peg10 by RNAi on diﬀerentiation
of 3T3-L1 cells into adipocytes
To characterize the functional role of this gene in adipogen-
esis, we next performed RNAi-mediated knockdown of peg10
during adipocyte diﬀerentiation. For the RNAi experiments,
three shRNA expression vectors named shpeg10-1, shpeg10-
2, and shpeg10-3 were constructed for targeting regions 1, 2,
and 3, respectively, in the ORF of the peg10 gene. These
shRNA expression vectors were transfected into 3T3-L1 cells.
Three hours after induction for diﬀerentiation, total RNA was
isolated, and then, the expression level of peg10 was deter-
mined by Q-PCR. We found that all three shRNA expression
vectors achieved an eﬀective silencing of peg10 expression, with
shpeg10-1 seeming to give the greatest reduction in activity
(Fig. 3A). Therefore, we used shpeg10-1 to perform RNAi
experiments for further analyses. Next, we determined the
expression level of peg10 in the cells transfected with
Fig. 2. Expression proﬁle of peg10 in the adipocyte diﬀerentiating and
non-diﬀerentiating cells. Total RNA isolated from growth-arrested
and proliferating 3T3-L1 and NIH-3T3 cells before and 3 h after
induction was subjected to Q-PCR. Each column represents the mean
with standard deviation (n = 3). N.D., not detected.
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conﬁrmed that the RNAi-treatment reduced the expression
of peg10 mRNA at each time-point in the diﬀerentiation pro-
cess (Fig. 3B). After 8 days, the cells were ﬁxed and stained
with Oil red O and the amounts of triacylglycerol were deter-
mined. The number of Oil red O-stained cells and the accumu-
lation of triacylglycerol were reduced among the RNAi-treated
cells (Fig. 3C).
Next, we determined the expression levels of adipogenic
marker genes by Q-PCR. The levels of aP2, PPARc, and C/
EBPa were remarkedly decreased at all the points examined
in the peg10 RNAi-treated cells, indicating that the knock-
down of peg10 inhibited the expression of adipogenic marker
genes as well as the accumulation of triacylglycerol. Taken to-
gether, the knockdown of peg10 inhibited the adipocyte diﬀer-
entiation. At the same time points, we also determined the
expression levels of C/EBPb and C/EBPd. Interestingly, the
knockdown did not have a remarkable eﬀect on the expression
of C/EBPb and C/EBPd, although C/EBPd levels at 0 and 8
days were decreased (Fig. 3D). This is discussed below. Final-
ly, to determine the eﬀects of two other vectors for the knock-
down of peg10 on adipogenesis, we performed RNAi
experiments using shpeg10-2, shpeg10-3, as well as shpeg10-1,
and determined the amounts of triacylglycerol in each of the
transfected cells at 8 days after the induction. As shown inFig. 1. Time course of peg10 mRNA expression during adipocyte diﬀerentiat
after treatment with inducers, and was subjected to Q-PCR, and normaliz
represents the mean with standard deviation (n = 3).Fig. 3E, we conﬁrmed that peg10 RNAi-treatment with
shpeg10-1 impaired adipocyte diﬀerentiation. In addition, theion. Total RNA was prepared from 3T3-L1 cells at various time points
ed with 18S rRNA expression determined by Q-PCR. Each column
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ation was also observed in RNAi experiments performed with
shpeg10-2, or shpeg10-3. Taken together, these results strongly
suggest that peg10 plays a crucial role in adipocyte diﬀerentia-
tion.
3.4. Eﬀect of peg10 RNAi-treatment on MCE
Peg10 was reported to promote cell growth in human hepa-
tocellular carcinoma [15,16]. We focused on the ability of
peg10 to promote cell growth, and next investigated the eﬀect
of peg10 on MCE. MCE is synchronous, transient cell growth
that can be observed after post-conﬂuent 3T3-L1 cells have
been treated with an optimal mixture of adipogenic stimulants
[17,18]. This phase is requisite for adipocyte diﬀerentiation,
followed by the expression of adipogenic genes, such asFig. 3. Eﬀect of the knockdown of peg10 by RNAi on adipocyte diﬀerentiatio
Total RNA obtained from 3T3-L1 cells transfected with shpeg10-1, shpeg10-
(control) at 3 h after diﬀerentiation was induced was subjected to Q-PCR. T
column represents the mean with standard deviation (n = 3). (B) peg10 expr
Total RNA obtained from 3T3-L1 cells transfected with shpeg10-1 (open bar
bars) at each time point was subjected to Q-PCR. The expression level was no
with standard deviation (n = 3). (C) Adipocyte diﬀerentiation of peg10-knock
the scramble shRNA expression vector as a control (control) were stimulate
detect oil droplets. The amount of triglyceride measured in peg10 knockdown
also shown. Each column represents the mean with standard deviation (n =
expression of various adipogenic genes. Total RNA obtained from peg10 kno
was subjected to Q-PCR, and normalized with 18S rRNA expression dete
deviation (n = 3). *P < 0.05; **P < 0.01 vs. control. (E) Eﬀects of three indepen
The amounts of triglyceride were measured at 8 days after the induction in
scrambled shRNA expression plasmid as a control (control). Each column rep
vs. control.PPARc and C/EBPa [19]. To elucidate the role of peg10 in
MCE, we determined the eﬀect of the knockdown of peg10
on MCE. This perceived eﬀect on MCE was quantiﬁed by tak-
ing cell counts with a hemocytometer at 1-day intervals
throughout the diﬀerentiation program. Cell numbers in con-
trol cultures increased 3.0-fold between days 0 and 4, and re-
mained constant between days 4 and 5. In comparison, cell
numbers in peg10 knockdown cultures only increased 2.4-fold
by day 4 (Fig. 4A). Similar results were obtained from RNAi
experiment performed with three independent shRNA expres-
sion vectors for peg10 (Fig. 4B), indicating that peg10 is critical
for MCE in adipogenesis.
Although little is known about the molecular mechanism of
the regulation of MCE, C/EBPb seems to play an important
role [20]. In this respect, we next investigated the expressionn. (A) The eﬀects of three diﬀerent shRNAs on the expression of peg10.
2, shpeg10-3 or the scrambled shRNA expression plasmid as a control
he expression level was normalized with 18S rRNA expression. Each
ession in peg10-knockdown 3T3-L1 cells was determined by Q-PCR.
s) or with the scrambled shRNA expression plasmid as a control (solid
rmalized with 18S rRNA expression. Each column represents the mean
down 3T3-L1 cells. The cells transfected with shpeg10-1 (shpeg10-1) or
d with inducers. After 8 days, the cells were stained with Oil red O to
cells (open bar) or control cells (solid bar) 8 days after the induction is
3). *P < 0.05 vs. control. (D) Eﬀect of peg10 RNAi-treatment on the
ckdown cells (open bars) or control cells (solid bars) at each time point
rmined by Q-PCR. Each column represents the mean with standard
dent shRNA expression vectors for peg10 knockdown on adipogenesis.
3T3-L1 cells transfected with shpeg10-1, shpeg10-2, shpeg10-3 or the
resents the mean with standard deviation (n = 3). *P < 0.05; **P < 0.01
Fig. 3 (continued)
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treated cells. Additionally, we determined the levels of C/
EBPd, which is transiently expressed immediately after the dif-
ferentiation is induced (Fig. 1) and known to facilitate the
expression of PPARc and C/EBPa, in cooperation with C/
EBPb [2,21]. Notably, RNAi-mediated knockdown of peg10
resulted in a reduction in the expression of C/EBPb and C/
EBPd in the immediate early stage of adipocyte diﬀerentiation
(Fig. 4C), although it did not have a clear eﬀect on the expres-
sion of these two genes at the late stage (Fig. 3D). These results
strongly indicate that peg10 lies upstream of C/EBPb and C/EBPd in the signaling pathway for adipocyte diﬀerentiation,
contributing to the expression of these two genes at the earliest
stage of diﬀerentiation.
On the basis of these ﬁndings, we now speculate that peg10
plays some role in MCE by regulating the expression of C/
EBPb and C/EBPd in the immediate early stage of the diﬀeren-
tiation process. Although CREB (cAMP response element
binding protein) is reported to regulate the expression of C/
EBPb and C/EBPd at the early stages of adipocyte diﬀerentia-
tion [22], the overall mechanisms regulating C/EBPb and
C/EBPd expression remain to be elucidated. In this regard,
Fig. 4. Eﬀect of peg10 RNAi-treatment on MCE and the expression of C/EBPb and C/EBPd at the immediate early stage of adipogenesis. (A) Eﬀect
of peg10 knockdown on MCE. The cells transfected with shpeg10-1 (peg10 knockdown) or the scramble shRNA expression vector as a control
(control) were stimulated with inducers. Parallel cultures of peg10 knockdown cells or control cells were harvested at the indicated days after
diﬀerentiation was induced. Cell numbers were determined by taking counts with a hemocytometer. Each column represents the mean with standard
deviation (n = 4). *P < 0.05; **P < 0.01 vs. control. (B) Eﬀects of three independent shRNA expression vectors for peg10 knockdown on MCE. The
cells transfected with shpeg10-1, shpeg10-2, shpeg10-3 or the scrambled shRNA expression plasmid as a control (control) were stimulated with
inducers. Parallel cultures of transfected cells were harvested at each time point after diﬀerentiation was induced. Cell numbers were determined by
taking counts with a hemocytometer. Each column represents the mean with standard deviation (n = 4). *P < 0.05; **P < 0.01 vs. control. (C) The
expression of C/EBPb and C/EBPd mRNA at the immediate early stage of adipogenesis was determined. Total RNA obtained from peg10
knockdown cells (open bars) or control cells (solid bars) at each time point was subjected to Q-PCR. Expression levels were normalized with 18S
rRNA expression determined by Q-PCR. Each column represents the mean with standard deviation (n = 3). *P < 0.05; **P < 0.01 vs. control.
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vide new insights into the early stages of adipocyte diﬀerentia-
tion. For the purpose of investigating the function of peg10 in
adipocyte diﬀerentiation in detail, analyses of PEG10 proteins,
namely PEG10-RF1 and PEG10-RF1/2, are ongoing.
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